Form 8-K - Current report:
SEC Accession No. 0001493152-24-028050
Filing Date
2024-07-16
Accepted
2024-07-16 17:26:44
Documents
19
Period of Report
2024-07-16
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43332
2 ex10-1.htm EX-10.1 4889
3 ex10-1_001.jpg GRAPHIC 401738
4 ex10-1_002.jpg GRAPHIC 251424
5 ex10-1_003.jpg GRAPHIC 272247
6 ex10-1_004.jpg GRAPHIC 65348
7 ex10-1_005.jpg GRAPHIC 60357
  Complete submission text file 0001493152-24-028050.txt   1672064

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE btcy-20240716.xsd EX-101.SCH 3021
9 XBRL LABEL FILE btcy-20240716_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE btcy-20240716_pre.xml EX-101.PRE 22363
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3683
Mailing Address 203 REDWOOD PARKWAY SUITE 600 REDWOOD CITY CA 94065
Business Address 203 REDWOOD PARKWAY SUITE 600 REDWOOD CITY CA 94065 (650) 832-1626
BIOTRICITY INC. (Filer) CIK: 0001630113 (see all company filings)

EIN.: 472548273 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-40761 | Film No.: 241120447
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)